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Abstract
Background: Although stroke is acknowledged as a long-term condition, population estimates of outcomes longer term are
lacking. Such estimates would be useful for planning health services and developing research that might ultimately improve
outcomes. This burden of disease study provides population-based estimates of outcomes with a focus on disability,
cognition, and psychological outcomes up to 10 y after initial stroke event in a multi-ethnic European population.
Methods and Findings: Data were collected from the population-based South London Stroke Register, a prospective
population-based register documenting all first in a lifetime strokes since 1 January 1995 in a multi-ethnic inner city
population. The outcomes assessed are reported as estimates of need and included disability (Barthel Index ,15), inactivity
(Frenchay Activities Index ,15), cognitive impairment (Abbreviated Mental Test , 8 or Mini-Mental State Exam ,24),
anxiety and depression (Hospital Anxiety and Depression Scale .10), and mental and physical domain scores of the Medical
Outcomes Study 12-item short form (SF-12) health survey. Estimates were stratified by age, gender, and ethnicity, and age-
adjusted using the standard European population. Plots of outcome estimates over time were constructed to examine
temporal trends and sociodemographic differences. Between 1995 and 2006, 3,373 first-ever strokes were registered: 20%–
30% of survivors had a poor outcome over 10 y of follow-up. The highest rate of disability was observed 7 d after stroke and
remained at around 110 per 1,000 stroke survivors from 3 mo to 10 y. Rates of inactivity and cognitive impairment both
declined up to 1 y (280/1,000 and 180/1,000 survivors, respectively); thereafter rates of inactivity remained stable till year
eight, then increased, whereas rates of cognitive impairment fluctuated till year eight, then increased. Anxiety and
depression showed some fluctuation over time, with a rate of 350 and 310 per 1,000 stroke survivors, respectively. SF-12
scores showed little variation from 3 mo to 10 y after stroke. Inactivity was higher in males at all time points, and in white
compared to black stroke survivors, although black survivors reported better outcomes in the SF-12 physical domain. No
other major differences were observed by gender or ethnicity. Increased age was associated with higher rates of disability,
inactivity, and cognitive impairment.
Conclusions: Between 20% and 30% of stroke survivors have a poor range of outcomes up to 10 y after stroke. Such
epidemiological data demonstrate the sociodemographic groups that are most affected longer term and should be used to
develop longer term management strategies that reduce the significant poor outcomes of this group, for whom effective
interventions are currently elusive.
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The World Health Organization’s Global Burden of Disease
analyses rely on routine mortality and limited disability data
throughout most countries worldwide. These data have persis-
tently highlighted stroke as the fourth leading cause of disability-
adjusted life years (DALYs) lost (stroke accounts for 6.3% DALYs,
equating to 83.61 million DALYs in low and middle income
countries and 9.35 million DALYs in high income countries) [1].
To estimate DALYs, a range of data sources, including disease
registers, epidemiological studies, and health surveys, are utilised,
yet the data that inform the DALY estimates for long-term
planning are not at all comprehensive.
Stroke is a condition that requires long-term management, and
some strategies to address such issues as rehabilitation, psycho-
logical treatments, and social support have been advocated at a
national level in the United Kingdom [2]. Yet estimates of
different outcomes after stroke in the long term, after 1 y, are
lacking, with most of the existing data on stroke outcomes and
costs being restricted to short-term cohort studies with limited
follow-up (usually up to 1 y), as well as focussing on disability alone
or relatively few outcome measures only. Additionally, selection
bias due to inclusion of only patients referred to hospitals and/or
rehabilitation settings often occurs. In the few population-based
follow-up studies, quality of life has been assessed between 2 and
21 y after stroke [3–7], and activities of daily living have been
assessed at 1, 3, 8, 16, and 21 y after stroke in a follow-up study in
Auckland [3], up to 5 y after stroke in Perth, Australia, and 5 y
after stroke in South London [7–9].
The aim of this burden of disease study is to generate
population-based estimates of long-term outcomes after stroke
using data for up to 10 y of follow-up in an unbiased population
sample, the South London Stroke Register (SLSR).
Methods
Study Population
The SLSR is a prospective population-based stroke register set
up in January 1995, recording all first-ever strokes in patients of all
ages for an inner area of South London based on 22 electoral
wards in Lambeth and Southwark. Data collected between 1995
and 2006 were used in this analysis, and the denominator
population was derived from 1991 and 2001 Census data with
mid-year adjustments [10,11].
The total source population of the SLSR area was 271,817
individuals, self-reported as 63% White, 28% Black (9% Black
Caribbean, 15% Black African, and 4% Black Other), and 9% Of
Other Ethnic Group in the 2001 census. Between the most recent
censuses of 1991 and 2001, the proportion of individuals in ethnic
groups other than White increased from 28% to 37%; in 1991, the
largest ethnic minority group was Black Caribbeans (11%), but by
2001, Black Africans made up the largest ethnic minority group
(15%) [10,11].
Case Ascertainment
Standardised criteria were applied to ensure completeness of
case ascertainment, including multiple overlapping sources of
notification [10,11]. Stroke was defined according to World
Health Organization criteria [10], and all subarachnoid haemor-
rhages (ICD-10 code I60.–), intracerebral haemorrhages (I61.–),
cerebral infarctions (I63.–), and unspecified strokes (I64) were
included. Patients admitted to hospitals serving the study area (two
teaching hospitals within and three hospitals outside the study
area) were identified by regular reviews of acute wards admitting
stroke patients, weekly checks of brain imaging referrals, and
monthly reviews of bereavement officer and bed manager records.
Additionally, national data on patients admitted to any hospital in
England and Wales with a diagnosis of stroke were also screened
for additional patients. To identify patients not admitted to
hospital, all general practitioners within and on the borders of the
study area were contacted regularly and asked to notify the SLSR
of stroke patients. Regular communication with general practi-
tioners was achieved by telephone contact and quarterly
newsletters. Referral of non-hospitalised stroke patients to a
neurovascular outpatient clinic (from 2003) or domiciliary visit to
patients by the study team was also available to general
practitioners. Community therapists were contacted every 3 mo.
Death certificates were checked regularly. Completeness of case
ascertainment has been estimated at 88% by a multinomial-logit
capture-recapture model using the methods described in detail
elsewhere [10].
Data Collection
Specially trained study nurses and field workers collected all
data prospectively whenever feasible. A study doctor verified the
diagnosis of stroke. Patients were examined within 48 h of referral
to SLSR where possible. The following sociodemographic
Table 1. Sociodemographics, stroke subtype, and case
fatality of SLSR patients, 1995–2006.
Characteristic Subcategory Value (n=3,373)
Age, mean (standard
deviation)
70.3 (14.6)
Age, n (%) ,65 y 1,038 (30.8)
65–74 y 891 (26.4)
75–84 y 956 (28.3)
85+y 488 (4.5)
Female sex, n (%) 1,663 (49.3)
Ethnicity, n (%) White 2,451 (72.7)
Black 645 (19.1)
Other 187 (5.5)
Unknown 90 (2.7)
Socioeconomic
status, n (%)
Non-manual 870 (26.7)
Manual 1,877 (55.3)
Economically inactive 499 (14.8)
Unknown 127 (3.8)
BI prior to stroke, n (%) 20, independent 2,505 (77.8)
15–19, mild disability 492 (15.3)
0–14, moderate-severe
disability
225 (7.0)
Stroke subtype, n (%) Infarction 2,470 (76.5)
Primary intracerebral
haemorrhage
464 (13.8)
Subarachnoid haemorrhage 193 (5.7)
Undefined 246 (7.3)
Cumulative survival, %
(95% CI)
1 y 63.7 (61.2–65.3)
5 y 42.8 (41.0–44.5)
10 y 24.0 (22.1–26.0)
doi:10.1371/journal.pmed.1001033.t001
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ethnic origin (census question), stratified into White, Black (Black
Caribbean, Black African, and Black Other), and Other Ethnic
Group. Socioeconomic status was categorised as non-manual (I, II,
and III non-manual), manual (III manual, IV, and V), and
economically inactive (retired and no information on previous
employment), according to the patient’s current or most recent
employment using the UK General Register Office occupational
codes. Classification of pathological stroke subtype (ischaemic
stroke, primary intracerebral haemorrhage, or subarachnoid
haemorrhage) was based on results from at least one of the
following: brain imaging performed within 30 d of stroke onset
(computerised tomography or magnetic resonance imaging),
cerebrospinal fluid analysis (in all living cases of subarachnoid
haemorrhage where brain imaging was not diagnostic), or
necropsy examination. Cases without pathological confirmation
of stroke subtype were classified as undefined [10,11]. The
Glasgow Coma Score dichotomised to ,13 or $13 was used as a
standardised measure of stroke severity (Table 1) [10,11].
Follow-up data were collected by validated postal or face-to-face
instruments with patients and/or their carers, the interview lasting
less than 1 h. If a patient had left the SLSR area, they were
followed up if at all possible using the methods described. Patients
were assessed at 3 mo and annually after stroke. All follow-up
assessments included in the present study were completed by 31
August 2009. Outcome measures included activity of daily living
using the Barthel Index (BI) [12], extended activities of daily living
(social activities) using the Frenchay Activities Index (FAI) [13],
health-related quality of life (HRQOL) using the UK version of
the Medical Outcomes Study 12-item short form (SF-12) or 36-
item short form (SF-36) surveys [14,15], cognitive impairment
using the Mini-Mental State Exam (MMSE) [16] or Abbreviated
Metal Test [17], and anxiety and depression using the Hospital
Anxiety and Depression Scale [18]. All interviewers underwent
regular standardised training in the use of the different scales.
Cut-off points for determining poor outcomes were defined a
priori. The BI was assessed in the acute phase (7–10 d after stroke)
and at all follow-up interviews. A score on the BI of ,15 was used
to identify patients with moderate (BI=10–14) to severe (BI ,9)
disability [19]. The FAI was administered at all follow-up points,
and participants with a score ,15 categorised as ‘‘inactive’’ [20].
The SF-36 was used to measure HRQOL in follow-up
interviews conducted before 1 March 1999, after which the
shortened version, the SF-12, was introduced. The 12 items of the
SF-12 have been adopted from the SF-36 verbatim, and summary
scores are replicable and reproducible [15,21]. Therefore, the
specific items from the SF-36 questionnaires in earlier follow-ups
were used to derive SF-12 summary scores across all time points.
The SF-12 was selected to measure HRQOL because of its strong
psychometric properties, wide use, reliability, validity, and
responsiveness [20,22]. It assesses eight domains of health status,
called physical functioning, role physical, bodily pain, general
health, vitality, social functioning, role emotional, and mental
health. Each domain is scored from 0 to 100. Absence of problems
is indicated by scores of 100 for physical functioning, role physical,
bodily pain, social functioning, and role emotional, and scores of
50 in general health, vitality, and mental health. These domains
were then used to produce two summary scores representing
physical and mental health [15]. Domains for the physical health
summary score included physical functioning, role physical, bodily
pain, and general health. The mental health summary score
included the domains vitality, social functioning, role emotional,
and mental health. The summary scores ranged from 0 to 100 and
were based on norms with a mean of 50 and a standard deviation
of 10. Summary scores in this study are presented as 100-score,
with higher values signifying poorer outcome.
Cognitive state was assessed in the acute phase as well as at
follow-up. Prior to 1 January 2000, all assessments were conducted
using the MMSE; after 1 January 2000, the Abbreviated Metal
Test was administered. Subjects were defined as cognitively
impaired according to predefined cut-off points (MMSE ,24 or
Abbreviated Mental Test ,8) [22,23].
The Hospital Anxiety and Depression Scale, consisting of two
subscales, was originally developed as a screening tool for anxiety
and depression in hospital patients but has also been validated for
use in stroke patients [24] and in the general population [25].
Each subscale is scored from 0 to 21 and used to identify possible
(score .7) cases of anxiety and depression [25].
Table 2. Population estimates of outcomes measured in the SLSR follow-up assessments.
Measure
SLSR Estimate for
Stroke Patients Non-Stroke Population Estimate
Reference for Non-Stroke
Population Estimate
Disability 11% 37% men; 40% women at least one functional
limitation (.65 y)
26
Cognition 18% (MMSE ,24) .65 y: 8.5%–9.8%, .75 y: 18.3% (MMSE ,22) 27
75–79 y: 11.2% $80 y: 46.5% (MMSE ,24) 28
.65 y: 4.6% (CARE Schedule
a)2 9
Depression 31% 8.7%–13.5% 29,30
Anxiety 35% 3.7% 29
SF-12 physical health, age ,65 y 62.3 50.0 31
SF-12 physical health, age 65–74 y 64.2 54.7 31
SF-12 physical health, age $75 y 65.4
SF-12 mental health, age ,65 y 54.7 48.6 31
SF-12 mental health, age 65–74 y 52.1 46.8 31
SF-12 mental health, age $75 y 51.8
For SF-12 scores, higher score indicates poorer health.
aA validated structured interview schedule that includes an ‘‘organic brain syndrome’’ subscale, used to identify cognitive impairment.
doi:10.1371/journal.pmed.1001033.t002
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doi:10.1371/journal.pmed.1001033.g001
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population samples. We searched for papers with outcomes
identical to those of this study and with age groups as near as
possible to those of this study. Apart from the PubMed search we
also included data from the Health Survey for England [26–31].
Statistical Analysis
Kaplan–Meier estimates were used to model survival and to
measure the cumulative survival and 95% confidence intervals at 1,
5, and 10 y after stroke. Proportions and pointwise 95% confidence
intervals were calculated based on the binomial distribution at all
time points for rates of disability, inactivity (extended activities of
daily living), cognitive impairment, anxiety, and depression [32].
For the SF-12 mental and physical domains, means and pointwise
95% confidence intervals were calculated using the Student’s t-
distribution. Estimates were stratified by gender, age, and ethnicity.
The standard European population [33] was used to provide age-
adjusted estimates in all analyses apart from those stratified by age.
All data available at each time point were considered.
A number of sensitivity analyses were carried out to assess the
robustness of results. Possible changes in outcomes by calendar
year were assessed by analysing rates and means at 1 and 5 y after
stroke by year of stroke. In a complete case analysis, only survivors
with data at all points up to 5 y after stroke were considered. In a
final analysis, missing data for survivors were imputed at all time
points using a best- and then worst-case scenario for binary
outcomes and assuming a score of 50 in the SF-12 domains.
Loss to follow-up rates varied by time point (after accounting for
deaths): 3 mo (24%); 1 y (17.9%); 2 y (29.1%, but data not
collected in 1998/1999); 3 y (18.9%); 4 y (16.8%); 5 y (18.5%); 6 y
(15.4%); 7 y (14.2%); 8 y (12.3%), 9 y (12.6%); 10 y (11.7%).
Figure 1 details the follow-up annually of this cohort over the 10 y.
The number of patients who died between two time points and the
number not eligible due to the later time point not yet being
reached are provided in the right-hand column. These participants
are subsequently ineligible for any future follow-up. In the left-
hand column the numbers followed up are included, with details of
those lost to follow-up and notified late. Late notification refers to
those not notified until after the specified time point in the Figure 1;
for example, lost notification at 9 y was in a patient first identified
at 9 y after the initial event.
These participants (lost to follow-up and late notifications)
remain in the sample eligible for future follow-ups. All analyses
were performed using Stata 10SE [34] and R 2.8.1 [35].
Ethics
All patients and/or their relatives gave written informed consent
to participate in the study, and over the study period very few
patients have declined to be registered. The design of the study
was approved by the ethics committees of Guy’s and St Thomas’
NHS Foundation Trust, King’s College Hospital Foundation
Trust, St George’s University Hospital, National Hospital for
Nervous Diseases, and Westminster Hospital.
Results
A total of 3,373 patients with first-ever stroke between 1 January
1995 and 31 December 2006 were registered in the SLSR. The
sociodemographic data, pathological stroke subtype data, and case
fatality rates are presented in Table 1. Mean age was 70.3 y
(standard deviation 14.6), and 49.3% were female (Table 1). Most
patients were white (72.7%), followed by black (Black African and
Black Caribbean) (19.1%), while other or unknown ethnicity was
recorded in less than 10%. The majority of patients were classified
as independent by the BI prior to stroke (77.8%). Ischaemic strokes
were observed in 76.5%, primary intracerebral haemorrhage in
13.8%, and subarachnoid haemorrhage in 5.7%. The Glasgow
Coma Score dichotomised to ,13 or $13, as a standardised
measure of stroke severity, showed no change over time after
adjusting for age, gender, ethnicity, and subtype of stroke.
Cumulative survival up to 10 y after stroke is displayed in
Figure 2, with 63.7%, 42.8%, and 24.0% surviving up to 1, 5, and
10 y, respectively.
The highest proportion of disabled stroke survivors was
observed 7 d after stroke, while the proportion remained at
around 110 per 1,000 stroke survivors after 3 mo (Figure 3).
Rates of inactivity, measured by the FAI, declined in the first
year after stroke, then remained stable till year eight, then
increased, whereas rates of cognitive impairment fluctuated till
year eight, then increased. Anxiety and depression showed
variation up to 10 y, with average rates around 350 and 310 per
1,000 population, respectively. Mean HRQOL physical domain
stroke summary scores were also quite stable from 3 mo to 10 y
after stroke (Figure 3), whereas mental domain stroke summary
scores fluctuated.
Levels of inactivity (FAI) were higher in males at all time points
(Figure 4). No other major differences were observed between
males and females. Higher levels of inactivity (FAI) were observed
in white compared with black stroke survivors, although the white
group showed a more favourable outcome in the HRQOL
physical domain (Figure 5). Age was directly associated with rates
of disability, inactivity, and cognitive impairment, while there was
no clear association between age and anxiety and depression and
SF-12 mental and physical domains (Figure 6).
In sensitivity analyses, the rates and means of all outcomes at 1
and 5 y after stroke did not show large variation by year of stroke
(Figure S1). Additionally, complete case analysis showed rates and
means similar to those of the original analysis over the first 5 y of
follow-up (Figure S2). When best- and worst-case imputation
methods were applied, although overall rates were altered, the
trends over time closely followed those in the observed and
complete case analyses (Figure S3).
Discussion
This study analyses a population-based cohort of stroke patients
followed for up to 10 y. It not only provides population estimates,
to our knowledge for the first time, on the longer term outcomes in
a diverse inner city population but highlights that stroke is truly a
lifelong condition among survivors with ongoing poor outcomes. A
major observation is that after 3–12 mo the outcomes remain
relatively constant. There are some differences in the rates of the
different outcomes between sociodemographic groups that are
largely unexplained, but the effect of age on poorer outcomes
indicates a challenge to be faced in future years [36].
It is rare that population-based studies estimate this range of
outcomes in such a prospective manner, with up to 10 y of follow-
up. Previous studies have addressed very long term outcomes, but
only for certain selected outcomes and not annually [3–8]. The use
of these year-on-year point prevalence estimates, in, for example,
the World Health Organization’s Global Burden of Disease
estimates of DALYs, would provide more precise estimates based
on population observations [8].
This burden of disease study only estimates outcomes in stroke
survivors, with no comparison to non-stroke populations. The data
have not been analysed with prediction of outcome as a focus, and
further analyses of patterns and predictors of outcome in various
sociodemographic, stroke subtype, and case mix groups are
Outcomes Up to Ten Years after Stroke
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in the early assessment time points, patients with severe stroke are
included, and the rates of poor outcome might intuitively be
thought to be higher, but as individuals in this group die and
patients who had milder strokes survive, rates of poor outcome
may be expected to reduce. Another factor that may influence the
estimates of outcome and determine differences between groups is
stroke care itself, although the year of stroke in this analysis had no
effect on patterns of outcome. Previous work by McKevitt et al.
[37] did not find that any specific sociodemographic factors
influenced the uptake of effective acute stroke care and early
secondary prevention interventions in this population [37].
Table 2 benchmarks the outcome estimates from this study with
age-matched UK population survey data where the same or very
similar outcome instruments have been employed, and although
such comparisons are not as ideal as a case-control design to
estimate outcome differences, they do largely indicate poorer
outcomes in the stroke population, re-enforcing the World Health
Organization’s Global Burden of Disease analyses, except for
disability, where no population norms were reported using the BI
or a similar scale [1].
Disability has been reported up to 5 y after stroke, and a
delayed but significant functional decline has been observed in
survivors [38]. In this study, there was, as anticipated, a dramatic
reduction in activities of daily living to 2 y, followed by an
improvement and then a plateau, but with 10%–20% of patients
having moderate to severe disability at 10 y. Although the
evidence base for rehabilitation interventions early after stroke is
strong, how to reduce stroke-related disability in the longer term
remains unclear. Yet these estimates highlight that 20%–30% of
patients at any time point presumably require some sort of
ongoing assessment and rehabilitation intervention.
Activity, as measured by the FAI, remains relatively stable over
time, but with around 30% of survivors being classified as inactive.
There is an increase in inactivity, after adjustment for age, after
8 y, which may be a result of residual confounding from other
comorbidities. Activity may well be linked to disability but will also
have other drivers, and assessment of patients in terms of mobility
and ability to integrate into society should be canvassed and
solutions found either at a patient or group level.
We have previously reported that up to 3 y after stroke
cognitive impairment is present in approximately one-third of
survivors assessed using the MMSE [39]. Rates of cognitive deficit
fluctuate in this cohort to 8 y, then increase, and this may
represent progressive vascular dementia associated with stroke,
although we did not observe any particular patterns with age.
In a systematic review of the literature on post-stroke
depression, Hackett et al. [40] highlighted the range of different
scales and cut-offs used to define depression. The pooled estimate
of all stroke survivors experiencing depression was 33%, although
Figure 2. Kaplan–Meier survival estimates with 95% confidence intervals.
doi:10.1371/journal.pmed.1001033.g002
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and Depression Scale.
doi:10.1371/journal.pmed.1001033.g003
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doi:10.1371/journal.pmed.1001033.g004
Outcomes Up to Ten Years after Stroke
PLoS Medicine | www.plosmedicine.org 8 May 2011 | Volume 8 | Issue 5 | e1001033Figure 5. Age-adjusted rates of outcome per 1,000 stroke suvivors and mean SF-12 scores by ethnicity. HADS, Hospital Anxiety and
Depression Scale.
doi:10.1371/journal.pmed.1001033.g005
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PLoS Medicine | www.plosmedicine.org 9 May 2011 | Volume 8 | Issue 5 | e1001033Figure 6. Rates of outcome per 1,000 stroke suvivors and mean SF-12 scores by age. HADS, Hospital Anxiety and Depression Scale.
doi:10.1371/journal.pmed.1001033.g006
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our analyses confirm fluctuation in rates of depression over 10 y,
with an average of 31% of patients having depression. In
Martinique, depression at 5 y after stroke was estimated at
25.8%, using the Montgomery-Asberg Depression Rating Scale
[41].
HRQOL has been assessed up to 21 y after stroke in New
Zealand [2,3]. At 6 y after stroke, HRQOL was found to be
‘‘acceptable’’ for the majority of survivors, even though many
experienced ongoing limitation of physical function. At 21 y after
stroke, standardised mean SF-36 scores were similar to those for
the age-matched non-stroke population, suggesting that stroke
survivors live relatively successfully within the general population,
despite ongoing disability [3]. In this study, HRQOL scores
fluctuated around 50–60, with 100 representing poor HRQOL
scores in both physical and mental domains, and further analyses
of the relationship between HRQOL and the other domains of
outcome are required to fully understand why, in the face of
significant loss of activity and participation, HRQOL for stroke
patients appears to compare favourably with non-stroke popula-
tion values. There are unexplained fluctuations in the mental
domain estimates over time that are not observed in physical
outcomes.
The loss to follow-up rates, once deaths are accounted for, in
this study are less than 20% at each time point except at 3 mo and
2 y. One might have expected the highest follow-up rate at 3 mo;
however, a proportion of patients are registered retrospectively for
whom 3-mo assessment is not possible. This loss to follow-up may
introduce bias, yet estimates from analyses of the patients with
complete data did not differ significantly from those presented
here. Loss to follow-up may be an issue in certain socio-
demographic groups, although we have not been able to identify
such groups in this analysis. The healthier participants and those
from higher socioeconomic groups may be more likely to engage
in research follow-up. In other cohort and stroke register studies,
loss to follow-up rates are not often presented. Inner city
populations are mobile, with large numbers of migrant families.
Although we acknowledge this as a potential factor in loss to
follow-up, efforts were made for all patients’ changes of address to
be recorded from either hospital, general practice, or family
sources. Patients and their families were then assessed face to face
if at all possible, but if they had moved to another country, postal
questionnaires were often sent and returned.
This population-based study has produced estimates of outcome
clearly demonstrating the long-term nature of disabilities following
stroke. Such estimates can be incorporated into estimated DALYs
for stroke and serve as objective estimates of need for stroke
patients. These estimates should highlight to health and social
service providers that stroke patients should not be lost to the
health and social care system and that providers will need to
develop innovative solutions to address the poor outcomes after
stroke in the long term.
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Background. Every year, 15 million people have a stroke.
About 5 million of these people die within a few days, and
another 5 million are left disabled. Stroke occurs when the
brain’s blood supply is suddenly interrupted by a blood clot
blocking a blood vessel in the brain (ischemic stroke, the
commonest type of stroke) or by a blood vessel in the brain
bursting (hemorrhagic stroke). Deprived of the oxygen
normally carried to them by the blood, the brain cells near
the blockage die. The symptoms of stroke depend on which
part of the brain is damaged but include sudden weakness
or paralysis along one side of the body, vision loss in one or
both eyes, and confusion or trouble speaking or under-
standing speech. Anyone experiencing these symptoms
should seek immediate medical attention because prompt
treatment can limit the damage to the brain. Risk factors for
stroke include age (three-quarters of strokes occur in people
over 65 years old), high blood pressure, and heart disease.
Why Was This Study Done? Post-stroke rehabilitation can
help individuals overcome the physical disabilities caused by
stroke, and drugs and behavioral counseling can reduce the
risk of a second stroke. However, people can also have
problems with cognition (thinking, awareness, attention,
learning, judgment, and memory) after a stroke, and they
can become depressed or anxious. These ‘‘outcomes’’ can
persist for many years, but although stroke is acknowledged
as a long-term condition, most existing data on stroke
outcomes are limited to a year after the stroke and often
focus on disability alone. Longer term, more extensive
information is needed to help plan services and to help
develop research to improve outcomes. In this burden of
disease analysis, the researchers use follow-up data collected
by the prospective South London Stroke Register (SLSR) to
provide long-term population-based estimates of disability,
cognition, and psychological outcomes after a first stroke.
The SLSR has recorded and followed all patients of all ages in
an inner area of South London after their first-ever stroke
since 1995.
What Did the Researchers Do and Find? Between 1995
and 2006, the SLSR recorded 3,373 first-ever strokes. Patients
were examined within 48 hours of referral to SLSR, their
stroke diagnosis was verified, and their sociodemographic
characteristics (including age, gender, and ethnic origin)
were recorded. Study nurses and fieldworkers then assessed
the patients at three months and annually after the stroke for
disability (using the Barthel Index, which measures the ability
to, for example, eat unaided), inactivity (using the Frenchay
Activities Index, which measures participation in social
activities), and cognitive impairment (using the Abbre-
viated Mental Test or the Mini-Mental State Exam). Anxiety
and depression and the patients’ perceptions of their mental
and physical capabilities were also assessed. Using preset
cut-offs for each outcome, 20%–30% of stroke survivors had
a poor outcome over ten years of follow-up. So, for example,
110 individuals per 1,000 population were judged disabled
from three months to ten years, rates of inactivity remained
constant from year one to year eight, at 280 affected
individuals per 1,000 survivors, and rates of anxiety and
depression fluctuated over time but affected about a third of
the population. Notably, levels of inactivity were higher
among men than women at all time points and were higher
in white than in black stroke survivors. Finally, increased age
was associated with higher rates of disability, inactivity, and
cognitive impairment.
What Do These Findings Mean? Although the accuracy
of these findings may be affected by the loss of some
patients to follow-up, these population-based estimates of
outcome measures for survivors of a first-ever stroke for up
to ten years after the event provide concrete evidence that
stroke is a lifelong condition with ongoing poor outcomes.
They also identify the sociodemographic groups of patients
that are most affected in the longer term. Importantly, most
of the measured outcomes remain relatively constant (and
worse than outcomes in an age-matched non-stroke-
affected population) after 3–12 months, a result that needs
to be considered when planning services for stroke survivors.
In other words, these findings highlight the need for health
and social services to provide long-term, ongoing
assessment and rehabilitation for patients for many years
after a stroke.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001033.
N The US National Institute of Neurological Disorders and
Stroke provides information about all aspects of stroke (in
English and Spanish); the US National Institute of Health
SeniorHealth Web site has additional information about
stroke
N The Internet Stroke Center provides detailed information
about stroke for patients, families, and health professionals
(in English and Spanish)
N The UK National Health Service Choices Web site also
provides information about stroke for patients and their
families
N MedlinePlus has links to additional resources about stroke
(in English and Spanish)
N More information about the South London Stroke Register
is available
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